Stereotactic body radiation therapy for spine and non-spine bone metastases. GETUG (french society of urological radiation oncologists) recommendations using a national two-round modified Delphi survey

Vilotte, Florent; Pasquier, David; Blanchard, Pierre; Supiot, S.; Khalifa, J.; Schick, Ulrike; Lacornerie, T.; Vieillevigne, L.; Marre, D.; Chapet, O.; Latorzeff, I.; Magné, Nicolas; Meyer, E.; Cao, K.; Belkacémi, Yazid; Bibault, Jean‐Emmanuel; Berge-Lefranc, M.; Faivre, J.-C.; Gnep, K.; Guimas, V.; Hasbini, Ali; Langrand-Escure, J.; Hennequin, Christophe; Gräff, P.

doi:10.1016/j.ctro.2022.08.006

Cited by 4 publications

(3 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…To meet the expected increasing demand for spine SBRT, it is important that appropriate funding and resources are put into establishing and developing frameworks for the expansion of dedicated spine SBRT programs across multiple radiation oncology departments in Victoria, including in regional centres, for the safe delivery of spine SBRT. These include the training of clinicians through mentorship programs (similar to the UK SABR Consortium) to ensure consistency in practice across all centres with respect to contouring, as well as interpretation and the adherence of consensus recommendations and guidelines [ 48 , 49 ]. There is also a requirement for safe radiation therapy simulations, image guidance and quality assurance programs, such as those recommended by the Canadian Association of Radiation Oncology SBRT Task Force [ 50 ].…”

Section: Discussionmentioning

confidence: 99%

Stereotactic Body Radiation Therapy for Spine Metastases—Findings from an Australian Population-Based Study

Ong,

Milne,

Foroudi

et al. 2023

Current Oncology

View full text Add to dashboard Cite

Background: To evaluate the use of stereotactic body radiation therapy (SBRT) for spine metastases and the associated factors in Australia. Methods: The Victorian Radiotherapy Minimum Dataset, which captures all episodes of radiotherapy delivered in the state of Victoria, was accessed to evaluate the patterns and trends of SBRT for spine metastases. The primary outcome was SBRT use and associated factors. Results: There were 6244 patients who received 8861 courses of radiotherapy for spine metastases between 2012 and 2017. Of these, 277 (3%) courses were SBRT, which increased from 0.4% in 2012 to 5% in 2017 (P-trend < 0.001). There was a higher proportion of SBRT use in patients with prostate cancer (6%) and melanoma (4%) compared to other cancers (2–3%) (p < 0.001). Patients from the highest socioeconomic quintiles (5%) were more likely to be treated with SBRT compared to patients from the lowest socioeconomic quintiles (3%) (p < 0.001). There was a higher proportion of SBRT use in private radiotherapy centres (6%) compared to public radiotherapy centres (1%) (p < 0.001). No spine SBRT was delivered in regional centres. In multivariate analyses, the year of treatment, age, primary cancers and radiotherapy centres were independently associated with SBRT use. Conclusion: This is the first Australian population-based study quantifying the increasing use of spine SBRT; however, the overall use of spine SBRT remains low. We anticipate an ongoing increase in spine SBRT, as spine SBRT gradually becomes the standard-of-care treatment for painful spine metastases.

show abstract

Section: Discussionmentioning

confidence: 99%

Stereotactic Body Radiation Therapy for Spine Metastases—Findings from an Australian Population-Based Study

Ong,

Milne,

Foroudi

et al. 2023

Current Oncology

View full text Add to dashboard Cite

show abstract

“…En metástasis óseas no vertebrales la SBRT podría ser de utilidad en personas premenopáusicas con tumor primario controlado, adecuada respuesta a tratamiento sistémico, intervalo libre de enfermedad > 12 meses, metástasis dolorosas y subtipos moleculares de alto riesgo, no así en RH positivo y HER2 negativo 89,133 .…”

Section: Radioterapia Estereotáctica Corporal En Metástasis óSeas Y V...unclassified

Consenso mexicano de cáncer mamario. Manejo del cáncer de mama avanzado

Cervantes-Sánchez,

Hernández-Barragán,

Aldaco-Sarvide

et al. 2024

GAMO

View full text Add to dashboard Cite

El cáncer de mama es la neoplasia más frecuente y con mayor mortalidad en mujeres en todo el mundo. La décima actualización del Consenso Mexicano Sobre Diagnóstico y Tratamiento del Cáncer Mamario (2023) es publicada por sus autores en diferentes artículos. El presente artículo incluye el manejo de cáncer de mama avanzado, el tratamiento sistémico adyuvante, el papel de la cirugía y la radioterapia en enfermedad metastásica y el seguimiento posterior al tratamiento con intención curativa. La difusión de este consenso contribuye a la actualización y homogeneidad de criterios de manejo del cáncer mamario en etapas avanzadas.

show abstract

“…In the case of non-spine bone metastases, SBRT could be useful in pre-menopausal women with controlled primary tumor, satisfactory response to systemic treatment, disease-free interval > 12 months, painful metastases, and high-risk molecular subtypes but not for HR-positive and HER2-negative disease 89,133 .…”

Section: Sbrt For Bone and Vertebral Metastasesmentioning

confidence: 99%

Mexican breast cancer consensus. Management of advanced breast cancer

Cervantes-Sánchez,

Hernández-Barragán,

Aldaco-Sarvide

et al. 2024

GAMO

View full text Add to dashboard Cite

Breast cancer is the most common neoplasia, with the highest mortality in women worldwide. The 10 th update of the Mexican Consensus on Diagnosis and Treatment of Breast Cancer (2023) is published by its authors in different articles. This article includes the management of advanced breast cancer, the adjuvant systemic treatment, the role of surgery and radiotherapy in metastatic disease, and follow-up after treatment with curative intent. The dissemination of this consensus contributes to the updating and homogeneity of breast cancer management of advanced stages.

show abstract

Stereotactic body radiation therapy for spine and non-spine bone metastases. GETUG (french society of urological radiation oncologists) recommendations using a national two-round modified Delphi survey

Cited by 4 publications

References 52 publications

Stereotactic Body Radiation Therapy for Spine Metastases—Findings from an Australian Population-Based Study

Stereotactic Body Radiation Therapy for Spine Metastases—Findings from an Australian Population-Based Study

Consenso mexicano de cáncer mamario. Manejo del cáncer de mama avanzado

Mexican breast cancer consensus. Management of advanced breast cancer

Contact Info

Product

Resources

About